Voron et al. reported that VEGFA produced from cancer cells and stromal cells upregulated the expression level of PD-1 and other inhibitory checkpoints involved in CD8+ T cell exhaustion, and that VEGFR inhibitors inhibit immune regulatory function by targeting VEGFR signaling [28]. The gene discussed is VEGFA; the disease is cancer.